Predictive factors of radiographic progression in ankylosing spondylitis

Background/Aims The course of ankylosing spondylitis (AS) is rather variable, and the factors that predict radiographic progression remain largely obscure. In this study, we tried to determine the clinical factors and laboratory measures that are useful in predicting the radiographic progression of patients with AS. Methods In 64 consecutive patients with AS, we collected radiographic and laboratory data over 3 years. Radiographic data included images of the sacroiliac (SI) and hip joints and laboratory data included areas under the curve (AUC) of erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), alkaline phosphatase (ALP), and hemoglobin (Hb). We investigated associations among changes in radiographic scores, initial clinical manifestations and laboratory measurements. Results Changes in scores for the SI joint and lumbar spine did not correlate with AUC for ESR, CRP, or ALP. AUC for Hb did not significantly correlate with radiographic progression in any joint. Patients with hip arthritis at the initial visit showed significantly higher radiographic score changes after 3 years in the SI and hip joint compared to those without hip arthritis. Patients who had shoulder arthritis as the initial manifestation had significantly increased AUCs for ESR and CRP compared to those without shoulder arthritis. However, at 3 years, the change of the lumbar spine score was significantly higher in patients without shoulder arthritis. Conclusions These results indicate that hip arthritis at presentation is a useful clinical marker for predicting the structural damage to the SI and hip joint, and suggest that initial shoulder arthritis correlates with slower radiographic progression of the lumbar spine.

[1]  A. Boonen,et al.  Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. , 2010, Rheumatology.

[2]  S. Ozgoçmen,et al.  Acute-phase response, clinical measures and disease activity in ankylosing spondylitis. , 2007, Joint, bone, spine : revue du rhumatisme.

[3]  J. Braun,et al.  Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes , 2007, Annals of the rheumatic diseases.

[4]  F. Luyten,et al.  Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. , 2007, Arthritis and rheumatism.

[5]  H. Stein,et al.  Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone-cartilage interface and subchondral bone marrow. , 2006, Arthritis and rheumatism.

[6]  J. Braun,et al.  Assessments in ankylosing spondylitis. , 2006, Best practice & research. Clinical rheumatology.

[7]  S. van der Linden,et al.  How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured? , 2005, Arthritis and rheumatism.

[8]  M. Dougados,et al.  Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. , 2005, Rheumatology.

[9]  B. Dijkmans,et al.  Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). , 2005, Arthritis and rheumatism.

[10]  B Combe,et al.  How to predict prognosis in early rheumatoid arthritis. , 2005, Best practice & research. Clinical rheumatology.

[11]  M. A. van 't Hof,et al.  Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system , 2004, Annals of the rheumatic diseases.

[12]  C. D. Yoo,et al.  Clinical features of adult-onset ankylosing spondylitis in Korean patients: patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD. , 2004, Rheumatology.

[13]  M. Dougados,et al.  What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. , 2004, Arthritis and rheumatism.

[14]  M. Dougados,et al.  The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. , 2004, Arthritis & Rheumatism.

[15]  W. Ollier,et al.  Polymyalgia rheumatica and biopsy-proven giant cell arteritis exhibit different HLA-DRB1* associations. , 2003, The Journal of rheumatology.

[16]  M. Dougados,et al.  Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. , 2003, Arthritis and rheumatism.

[17]  E. Collantes-Estévez,et al.  Biological and clinical markers of disease activity in ankylosing spondylitis. , 2003, The Journal of rheumatology.

[18]  Sinead Brophy,et al.  The natural history of ankylosing spondylitis as defined by radiological progression. , 2002, The Journal of rheumatology.

[19]  G. Stucki,et al.  Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. , 1999, The Journal of rheumatology.

[20]  M. Dougados,et al.  Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. , 1999, The Journal of rheumatology.

[21]  F. caligaris-Cappio,et al.  ANEMIA OF CHRONIC DISORDERS IN SYSTEMIC AUTOIMMUNE DISEASES , 2022 .

[22]  W. Fraser,et al.  Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity. , 1997, British journal of rheumatology.

[23]  K. Federlin,et al.  Evidence of impaired cartilage/bone turnover in patients with active ankylosing spondylitis. , 1995, Annals of the rheumatic diseases.

[24]  M. Dougados,et al.  Predictive factors for the longterm outcome of spondyloarthropathies. , 1994, The Journal of rheumatology.

[25]  H. Bird,et al.  Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. , 1994, British journal of rheumatology.

[26]  S. Krantz,et al.  Progress in understanding the pathogenesis of the anemia of chronic disease. , 1992, Blood.

[27]  G. Birgegard,et al.  Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin. , 1992, Annals of the rheumatic diseases.

[28]  E.,et al.  Progress in Understanding the Pathogenesis of the Anemia of Chronic Disease , 1992 .

[29]  P. Dawes,et al.  The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis. , 1991, British journal of rheumatology.

[30]  J. Mathews,et al.  Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis. , 1986, British journal of rheumatology.

[31]  J. Rubenstein,et al.  The natural disease course of ankylosing spondylitis. , 1983, Arthritis and rheumatism.

[32]  E. L. Persons,et al.  Ankylosing Spondylitis , 1955, GP.